Clinical trial
A Phase I Clinical Study of CCX168 in Japanese and Caucasian Healthy Adult Males
NCT05988008 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Clinical Study of CCX168 in Japanese and Caucasian Healthy Adult Males
- Lead sponsor
- Amgen
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 23, 2017
- Completion date
- September 20, 2018
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.